LMAT
LeMaitre Vascular, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$101.69+0.06%
Price as of Jul 20, 2026
LMAT financials
LeMaitre Vascular, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M |
| Cost of revenue | $71.1M | $69.0M | $66.4M | $56.8M |
| Gross profit | $178.5M | $150.9M | $127.0M | $104.9M |
| Operating expenses | $110.6M | $98.6M | $90.3M | $78.1M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M |
| EBITDA | $90.8M | $66.8M | $49.0M | $36.9M |
| Basic EPS | $2.55 | $1.96 | $1.36 | $0.94 |
| Diluted EPS | $2.52 | $1.93 | $1.34 | $0.93 |
| Balance sheet | ||||
| Cash & equivalents | $28.2M | $25.6M | $24.3M | $19.1M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M |
| Stockholders’ equity | $393.5M | $337.3M | $297.9M | $268.2M |
| Total debt | $185.6M | $185.7M | $19.1M | $16.6M |
| Net debt | $157.3M | $160.1M | -$5.2M | -$2.5M |
| Cash flow | ||||
| Operating cash flow | $81.3M | $44.1M | $36.8M | $25.4M |
| Capital expenditure | -$6.8M | -$7.0M | -$7.3M | -$3.2M |
| Free cash flow | $74.5M | $37.2M | $29.5M | $22.1M |
| Dividends paid | -$18.1M | -$14.4M | -$12.4M | -$11.0M |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |